Page last updated: 2024-10-25

eflornithine and Carcinoma, Ductal, Breast

eflornithine has been researched along with Carcinoma, Ductal, Breast in 2 studies

Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.

Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ranger-Moore, J1
Alberts, DS1
Montironi, R1
Garcia, F1
Davis, J1
Frank, D1
Brewer, M1
Mariuzzi, GM1
Bartels, HG1
Bartels, PH1
Bacus, JW1
Boone, CW1
Bacus, JV1
Follen, M1
Kelloff, GJ1
Kagan, V1
Lippman, SM1

Other Studies

2 other studies available for eflornithine and Carcinoma, Ductal, Breast

ArticleYear
Karyometry in the early detection and chemoprevention of intraepithelial lesions.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:13

    Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Disease Progression;

2005
Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 1999, Volume: 8, Issue:12

    Topics: Antineoplastic Agents; Biopsy; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Cell

1999